Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2013 Apr;5(2):114-5.
doi: 10.3978/j.issn.2072-1439.2013.02.05.

Sodium tanshinone IIA sulfonate for pulmonary arterial hypertension: emerging therapeutic option

Affiliations

Sodium tanshinone IIA sulfonate for pulmonary arterial hypertension: emerging therapeutic option

Shahzad G Raja. J Thorac Dis. 2013 Apr.
No abstract available

PubMed Disclaimer

References

    1. Raja SG, Raja SM. Treating pulmonary arterial hypertension: current treatments and future prospects. Ther Adv Chronic Dis 2011;2:359-70 - PMC - PubMed
    1. Raja SG. Evaluation of clinical efficacy of fasudil for the treatment of pulmonary arterial hypertension. Recent Pat Cardiovasc Drug Discov 2012;7:100-4 - PubMed
    1. Raja SG. Endothelin receptor antagonists for pulmonary arterial hypertension: an overview. Cardiovasc Ther 2010;28:e65-71 - PubMed
    1. Raja SG, Danton MD, MacArthur KJ, et al. Treatment of pulmonary arterial hypertension with sildenafil: from pathophysiology to clinical evidence. J Cardiothorac Vasc Anesth 2006;20:722-35 - PubMed
    1. Raja SG, Nayak SH. Sildenafil: emerging cardiovascular indications. Ann Thorac Surg 2004;78:1496-506 - PubMed